GPT2 Gene Mental Retardation Autosomal Recessive Type 49 Genetic Test sale cost 4400 AED
TTI2 Gene Mental Retardation Autosomal Recessive Type 39 Genetic Test sale cost 4400 AED TTI2 Gene Mental Retardation Autosomal Recessive Type 39 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
HSD17B10 Gene Mental Retardation X-Linked Type 17 Genetic Test sale cost 4400 AED HSD17B10 Gene Mental Retardation X-Linked Type 17 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

GPT2 Gene Mental Retardation Autosomal Recessive Type 49 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GPT2 Gene Mental Retardation Autosomal Recessive Type 49 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GPT2 gene, which have been linked to autosomal recessive intellectual disability type 49. This condition is characterized by developmental delays, learning disabilities, and possibly other neurological or physical abnormalities. The test is crucial for families seeking answers to genetic questions related to intellectual disabilities, allowing for better understanding, management, and planning for affected individuals’ needs. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately analyze and interpret the genetic data. DNA Labs UAE, with its state-of-the-art facilities and experienced professionals, ensures a reliable and comprehensive assessment for those undergoing the test.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GPT2 Gene Mental Retardation Autosomal Recessive Type 49 Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Neurological Disorders

Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for GPT2 Gene Mental retardation, autosomal recessive type 49 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with GPT2 Gene Mental retardation, autosomal recessive type 49

Test Details

NGS Genetic Test for Mental Retardation, Autosomal Recessive Type 49

NGS (Next-Generation Sequencing) genetic testing is a powerful tool used to identify genetic variations and mutations associated with various conditions, including mental retardation.

In the case of Mental Retardation, Autosomal Recessive Type 49, NGS testing can be utilized to detect specific gene mutations responsible for this condition.

To perform the NGS genetic test for Mental Retardation, Autosomal Recessive Type 49, the following steps are typically followed:

  1. Sample Collection: A biological sample, usually blood or saliva, is collected from the individual undergoing testing. The sample contains the DNA necessary for genetic analysis.
  2. DNA Extraction: The DNA is extracted from the collected sample using specialized laboratory techniques. This ensures that the genetic material is isolated and purified for further analysis.
  3. Library Preparation: The extracted DNA is fragmented and specific adapters are added to the fragments. These adapters allow the DNA fragments to be amplified and sequenced.
  4. Sequencing: The prepared DNA library is loaded onto a sequencing instrument, such as an Illumina sequencer. The instrument performs high-throughput sequencing, generating millions of short DNA reads.
  5. Data Analysis: The raw sequencing data is processed and analyzed using specialized bioinformatics tools and algorithms. The goal is to align the DNA reads to a reference genome and identify genetic variations, including mutations associated with Mental Retardation, Autosomal Recessive Type 49.
  6. Variant Interpretation: The identified genetic variations are then interpreted by geneticists and clinicians. Variants that are known to be associated with Mental Retardation, Autosomal Recessive Type 49 are considered pathogenic or likely pathogenic.
  7. Genetic Counseling and Reporting: Once the analysis is complete, a comprehensive report is generated, summarizing the findings. This report is typically provided to the healthcare provider or genetic counselor, who can then discuss the results with the individual or their family.

NGS genetic testing for Mental Retardation, Autosomal Recessive Type 49 can help in diagnosing the condition, providing valuable information for treatment and management strategies, and facilitating genetic counseling for affected individuals and their families.

It is important to consult with a healthcare professional or genetic counselor to understand the implications of the test results and to make informed decisions regarding further medical care.

Test Name GPT2 Gene Mental retardation autosomal recessive type 49 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GPT2 Gene Mental retardation, autosomal recessive type 49 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GPT2 Gene Mental retardation, autosomal recessive type 49
Test Details

NGS Genetic Test for Mental Retardation, Autosomal Recessive Type 49

NGS (Next-Generation Sequencing) genetic testing is a powerful tool used to identify genetic variations and mutations associated with various conditions, including mental retardation. In the case of Mental Retardation, Autosomal Recessive Type 49, NGS testing can be utilized to detect specific gene mutations responsible for this condition.

To perform the NGS genetic test for Mental Retardation, Autosomal Recessive Type 49, the following steps are typically followed:

1. Sample Collection: A biological sample, usually blood or saliva, is collected from the individual undergoing testing. The sample contains the DNA necessary for genetic analysis.

2. DNA Extraction: The DNA is extracted from the collected sample using specialized laboratory techniques. This ensures that the genetic material is isolated and purified for further analysis.

3. Library Preparation: The extracted DNA is fragmented and specific adapters are added to the fragments. These adapters allow the DNA fragments to be amplified and sequenced.

4. Sequencing: The prepared DNA library is loaded onto a sequencing instrument, such as an Illumina sequencer. The instrument performs high-throughput sequencing, generating millions of short DNA reads.

5. Data Analysis: The raw sequencing data is processed and analyzed using specialized bioinformatics tools and algorithms. The goal is to align the DNA reads to a reference genome and identify genetic variations, including mutations associated with Mental Retardation, Autosomal Recessive Type 49.

6. Variant Interpretation: The identified genetic variations are then interpreted by geneticists and clinicians. Variants that are known to be associated with Mental Retardation, Autosomal Recessive Type 49 are considered pathogenic or likely pathogenic.

7. Genetic Counseling and Reporting: Once the analysis is complete, a comprehensive report is generated, summarizing the findings. This report is typically provided to the healthcare provider or genetic counselor, who can then discuss the results with the individual or their family.

NGS genetic testing for Mental Retardation, Autosomal Recessive Type 49 can help in diagnosing the condition, providing valuable information for treatment and management strategies, and facilitating genetic counseling for affected individuals and their families. It is important to consult with a healthcare professional or genetic counselor to understand the implications of the test results and to make informed decisions regarding further medical care.

SKU: TEST-1615 Category:

Related products